Glucose-Na-K Baxter (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Glucose, Sodium Acetate Trihydr)

Glucose-Na-K Baxter is used in clinical situations where rapid fluid and electrolyte replacement is required.

• Fluid and electrolyte replacement in patients with dehydration or volume loss.
• Management of hypoglycemia when glucose supplementation is needed.
• Post‑operative care to maintain electrolyte balance and support recovery.
• Treatment of acute electrolyte disturbances such as hyponatremia, hypokalemia, or hypomagnesemia.
• Support during renal replacement therapy or continuous infusion procedures.
• Adjunct therapy in severe burns or trauma to replenish lost salts and glucose.

Potential adverse reactions to Glucose-Na-K Baxter are generally related to its electrolyte composition and infusion characteristics.

Common

• Mild irritation or pain at the infusion site.
• Transient increase in blood sodium or potassium levels.
• Nausea or mild gastrointestinal discomfort.
• Slight rise in blood glucose concentration.
• Local swelling or edema at the infusion site.

Serious

• Hypermagnesemia leading to muscle weakness or cardiac arrhythmia.
• Severe electrolyte imbalance causing cardiac conduction disturbances.
• Allergic reaction such as rash, itching, or anaphylaxis.
• Pulmonary edema from rapid fluid overload.

When prescribing or administering Glucose-Na-K Baxter, clinicians should consider several safety precautions to minimize risks.

• Assess baseline electrolyte levels and renal function before infusion.
• Adjust infusion rate in patients with cardiac or renal impairment.
• Monitor blood glucose closely in diabetic or hypoglycemic patients.
• Avoid rapid large-volume administration to prevent fluid overload.
• Use aseptic technique to reduce infection risk.
• Consider compatibility with other intravenous medications before co‑administration.
• Discontinue if signs of severe electrolyte disturbance or allergic reaction appear.

Glucose-Na-K Baxter may interact with other drugs administered intravenously or orally, affecting electrolyte balance or drug efficacy.

Avoid

• Avoid concurrent infusion of potassium‑sparing diuretics that may cause hyperkalemia.
• Do not mix with calcium‑containing solutions, which can precipitate insoluble salts.

Use with caution

• Use cautiously with other magnesium‑containing products to prevent hypermagnesemia.
• Monitor closely when combined with insulin or oral hypoglycemics due to additive glucose effects.
• Adjust dosing when given with loop diuretics that alter sodium and potassium excretion.
• Be careful with nephrotoxic agents, as electrolyte shifts may exacerbate renal injury.